Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated